Cell-mediated immunity to chemically xenogenized tumors — IV. Production of lymphokine activity by, and in response to, highly immunogenic cells
- 1 January 1989
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 11 (5) , 537-542
- https://doi.org/10.1016/0192-0561(89)90183-5
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Induction of tumor suppression and delayed‐type footpad reaction by transfer of lymphocytes sensitized to a xenogenized tumor variantInternational Journal of Cancer, 1988
- Autocrine Growth of Murine Lymphoma CellsJNCI Journal of the National Cancer Institute, 1988
- Cell-mediated immunity to chemically xenogenized tumorsCellular Immunology, 1988
- Cell-mediated immunity to chemically xenogenized tumors—III. Generation of monoclonal antibodies interfering with reactivity to novel antigensInternational Journal of Immunopharmacology, 1988
- LymphokinesNew England Journal of Medicine, 1987
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- Systemic adoptive immunotherapy of a highly immunogenic murine lymphoma growing in the brainInternational Journal of Cancer, 1983
- IN VITRO GENERATION OF PRIMARY CYTOTOXIC LYMPHOCYTES AGAINST L5178Y LEUKEMIA ANTIGENICALLY ALTERED BY 5-(3,3'-DIMETHYL-l-TRIAZENO)-IMIDAZOLE-4-CARBOXAMIDE IN VIVOTransplantation, 1979
- GROWTH AND REJECTION PATTERNS OF MURINE LYMPHOMA CELLS ANTIGENICALLY ALTERED FOLLOWING DRUG TREATMENT IN VIVOTransplantation, 1978
- Cellular immune response to a drug-treated L5178Y lymphoma sublineNature, 1974